1. Brain-Stem Auditory Evoked Potentials in Human Immunodeficiency Virus-Seropositive Patients With and Without Acquired Immunodeficiency Syndrome
- Author
-
Pedro Cahn, Arnaldo Casiro, Héctor Pérez, Mirtha Amores, Héctor A. Figini, María C. Dellepiane, Miguel A. Pagano, Carlos A. Mangone, María Laura Garau, and Alberto Yorio
- Subjects
Adult ,Male ,Substance-Related Disorders ,Central nervous system ,Neural Conduction ,Human immunodeficiency virus (HIV) ,Physiology ,medicine.disease_cause ,Virus ,Arts and Humanities (miscellaneous) ,Acquired immunodeficiency syndrome (AIDS) ,Immunopathology ,HIV Seropositivity ,Evoked Potentials, Auditory, Brain Stem ,Humans ,Medicine ,Subclinical infection ,Acquired Immunodeficiency Syndrome ,business.industry ,Brain Stem Auditory Evoked Potentials ,Brain ,Middle Aged ,medicine.disease ,medicine.anatomical_structure ,Immunology ,Female ,Neurology (clinical) ,Viral disease ,business - Abstract
• Brain-stem auditory evoked potentials were recorded in 35 human immunodeficiency virus (HIV)—seropositive subjects from the Centers for Disease Control groups III and IV, 24 HIV-negative drug abusers, and 62 normal healthy controls. None of the patients had evidence of neurological complications. History of alcohol consumption was an exclusion criterion. The values of central conduction times I-V and III-V showed significant differences between the HIV-seropositive subjects and normal healthy controls, as well as between the HIV-seropositive subjects and HIV-negative drug abusers. Central conduction times I-III showed no differences between groups, except in the left ear of Centers for Disease Control group IV compared with controls. No statistical differences were found in the central conduction times between HIV-negative drug abusers and normal healthy controls. The results suggest a subclinical involvement of the upper brain stem in HIV infection. It could be produced by direct action of the virus on central nervous system structures.
- Published
- 1992
- Full Text
- View/download PDF